REQUEST A DEMO
Total
USD $0.00
Search more companies

Setpharma Ilac Danismanlik Ticaret Ltd. Sti. (Turkiye)

Main Activities: Other Management Consulting Services
Full name: Setpharma Ilac Danismanlik Ticaret Limited Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Setpharma Ilac Danismanlik Ticaret Ltd. Sti. is an enterprise based in Turkiye. Its main office is in Istanbul. It operates in the Other Management Consulting Services industry. It was first established on September 08, 2020. 4 (2024) employees currently work for Setpharma Ilac Danismanlik Ticaret Ltd. Sti.. From the latest financial highlights, Setpharma Ilac Danismanlik Ticaret Ltd. Sti. reported a net sales revenue increase of 967.82% in 2022. Its total assets grew by 63.03% over the same period. In, 2022, the company’s net profit margin decreased by 9.37%.

Headquarters
Park Apartmani No:4d/8 Merkez Mahallesi Esenyurt Sokak Cekmekoy
Istanbul; Marmara;

Contact Details: Purchase the Setpharma Ilac Danismanlik Ticaret Ltd. Sti. report to view the information.

Basic Information
Total Employees:
Purchase the Setpharma Ilac Danismanlik Ticaret Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Setpharma Ilac Danismanlik Ticaret Ltd. Sti. report to view the information.
Incorporation Date:
September 08, 2020
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Setpharma Ilac Danismanlik Ticaret Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
967.82%
Total operating revenue
967.82%
Operating profit (EBIT)
569.17%
Net Profit (Loss) for the Period
143.9%
Total Assets
63.03%
Total Equity
52.07%
Operating Profit Margin (ROS)
-7.85%
Net Profit Margin
-9.37%
Return on Equity (ROE)
12.89%
Debt/Equity
-122.79%
Quick Ratio
-0.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?